HHLR Advisors Ups BeiGene Stake to 10.4%

Ticker: BEIGF · Form: SC 13D/A · Filed: Dec 4, 2024 · CIK: 1651308

Sentiment: neutral

Topics: shareholder-filing, ownership-change, biotech

Related Tickers: BGNE

TL;DR

HHLR Advisors now owns 10.4% of BeiGene after filing an amendment. Big move.

AI Summary

On December 4, 2024, HHLR Advisors, Ltd. filed an amendment (No. 5) to its Schedule 13D concerning BeiGene, Ltd. The filing indicates a change in beneficial ownership, with HHLR Advisors, Ltd. now holding 10.4% of BeiGene's ordinary shares. This filing follows a previous amendment on November 27, 2024.

Why It Matters

Significant changes in major shareholder holdings can signal shifts in company strategy or investor sentiment, potentially impacting stock price and future corporate actions.

Risk Assessment

Risk Level: medium — Changes in significant shareholder stakes can lead to increased volatility and potential shifts in company control or strategy.

Key Numbers

Key Players & Entities

FAQ

What was the previous ownership percentage of HHLR Advisors, Ltd. before this amendment?

The filing does not explicitly state the previous percentage in this amendment, but it indicates a change from a prior filing.

What is the total number of ordinary shares outstanding for BeiGene, Ltd.?

This specific filing does not disclose the total number of ordinary shares outstanding for BeiGene, Ltd.

What is the primary business of BeiGene, Ltd.?

BeiGene, Ltd. is in the business of Pharmaceutical Preparations, as indicated by its SIC code [2834].

Who is listed as a contact person for BeiGene, Ltd. in this filing?

Richard A. is mentioned at the end of the provided text snippet, though his specific role is not detailed.

What is the significance of the 'FORM TYPE: SC 13D/A' designation?

SC 13D/A signifies a filing under the Securities Exchange Act of 1934, specifically an amendment to a Schedule 13D, which is used by significant beneficial owners of a company's securities.

Filing Stats: 1,068 words · 4 min read · ~4 pages · Grade level 11.4 · Accepted 2024-12-04 16:05:33

Key Financial Figures

Filing Documents

From the Filing

SC 13D/A 1 p24-3466sc13da.htm BEIGENE, LTD. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* BeiGene, Ltd. (Name of Issuer) Ordinary shares, par value $0.0001 per share (Title of Class of Securities) 07725L102 (CUSIP Number) Richard A. Hornung HHLR Advisors, Ltd. Office #122, Windward 3 Building, Regatta Office Park West Bay Road, Grand Cayman Cayman Islands, KY1-9006 With a copy to: Eleazer N. Klein, Esq. Adriana F. Schwartz, Esq. Schulte Roth & Zabel LLP 919 Third Avenue New York, NY 10022 (212) 756-2000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 2, 2024 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [ ] (Page 1 of 5 Pages) ______________________________ * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 07725L102 SCHEDULE 13D/A Page 2 of 5 Pages 1 NAME OF REPORTING PERSON HHLR Advisors, Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 SOURCE OF FUNDS AF (See Item 3) 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 7 SOLE VOTING POWER -0- 8 SHARED VOTING POWER 125,045,741 Ordinary Shares* 9 SOLE DISPOSITIVE POWER -0- 10 SHARED DISPOSITIVE POWER 125,045,741 Ordinary Shares* 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 125,045,741 Ordinary Shares* 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.0% 14 TYPE OF REPORTING PERSON IA * Consists of (i) 111,597,423 ordinary shares held by a fund managed by HHLR (as defined below), of which 36,011,300 ordinary shares are held in the form of 2,770,100 ADSs and (ii) 13,448,318 ordinary shares held by a fund managed by HIM (as defined below), of which 13,445,978 ordinary shares are held in the form of 1,034,306 ADSs. HHLR and HIM are under common control and share certain policies, personnel and resources. CUSIP No. 07725L102 SCHEDULE 13D/A Page 3 of 5 Pages 1 NAME OF REPORTING PERSON Hillhouse Investment Management, Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 SOURCE OF FUNDS AF (See Item 3) 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 7 SOLE VOTING POWER -0- 8 SHARED VOTING POWER 125,045,741 Ordinary Shares* 9 SOLE DISPOSITIVE POWER -0- 10 SHARED DISPOSITIVE POWER 125,045,741 Ordinary Shares* 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 125,045,741 Ordinary Shares* 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.0% 14 TYPE OF REPORTING PERSON IA * Consists of (i) 111,597,423 ordinary shares held by a fund managed by HHLR, of which 36,011,300 ordinary shares are held in the form of 2,770,100 ADSs and (ii) 13,448,318 ordinary shares held by a fund managed by HIM, of which 13,445,978 ordinary shares are held in the form of 1,034,306 ADSs. HHLR and HIM are under common control and share certain policies, personnel and resources. CUSIP No. 07725L102 SCHEDULE 13D/A Page 4 of 5 Pages This Amendment No. 5 (" Amendment No. 5 ") amends the statement on Schedule 13D previously filed by the Reporting Persons with the Securities and Exchange Commission (the " SEC ") (as previously filed and amended and amended further hereby, the " Schedule 13D ") with respect to the ordinary shares, par value $0.0001 per share (the " Ordinary Shares ") of BeiGene, Ltd., an exempted Cayman Islands company (the " Issuer "). Capitalized terms used herein and not otherwise defined in this Amendment No. 5 have the meanings set forth in the Schedule 13D. This Amendment No. 5 amen

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing